59
Views
33
CrossRef citations to date
0
Altmetric
Research Article

DEXRAZOXANE - A PROMISING ANTIDOTE IN THE TREATMENT OF ACCIDENTAL EXTRAVASATION OF ANTHRACYCLINES

, , &
Pages 174-175 | Published online: 08 Jul 2009

  • Bowers DG Jr, Lynch JB. Adriamycin extravasation. Plast Reconstr Surg 1978; 61: 86-92.
  • Dahlstrom KK, Chenoufl HL, Daugaard S. Fluorescence microscopic demonstration and demarcation of doxorubicin extravasation. Experimental and clinical studies. Cancer 1990; 65: 1722-1726.
  • Disa JJ, Chang RR, Mucci SJ, Goldberg NH. Prevention of adriamycin-induced full-thickness skin loss using hyaluronidase infiltration. Plast Reconstr Surg 1998; 101: 370-374.
  • Langer SW, Sehested M, Jensen PB. Dexrazoxane protects against anthracycline extravasation. Clin Cancer Res 2000; 6: 3680-3686.
  • Langer SW, Sehested M, Jensen PB, Buter J, Giaccone G. Dexrazoxane in anthracycline extravasation [letter]. J Clin Oncol 2000; 18: 3064.
  • Langer SW, Sehested M, Jensen PB. Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice. Ann Oncol 2001; 12: 405-410.
  • Larson DL. Treatment of tissue extravasation by antitumor agents. Cancer 1982; 49: 1796-1799.
  • Larson DL. What is the appropriate management of tissue extravasation by antitumor agents? Plast Reconstr Surg 1985; 75: 397-405.
  • Olver IN, Aisner J, Hament A, Buchanan L, Bishop JF, Kaplan RS. A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation. J Clin Oncol 1988; 6: 1732-1735.
  • Scuderi N, Onesti MG. Antitumor agents: extravasation, management, and surgical treatment. Ann Plast Surg 1994; 32: 39-44.
  • Tsavaris NB, Karagiaouris P, Tzannou I et al. Conservative approach to the treatment of chemotherapyinduced extravasation. J Dermatol Surg Oncol 1990; 16: 519-522.
  • Vandemeyer E, Deraemaecker R. Early surgical suction and washout for treatment of cytotoxic drug extravasations. Acta Chir BeIg 2000; 100: 37-38.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.